Compounds > ranolazine
Page last updated: 2024-08-24

ranolazine and isoproterenol

ranolazine has been researched along with isoproterenol in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Allen, TJ; Chapman, RA1
John, GW; Le Grand, B; Létienne, R; Puech, A; Vié, B; Vieu, S1
Gong, S; Guan, T; Li, Y; Sun, H; Wu, X; Yao, Z1
Baker, SP; Belardinelli, L; Hintze, TH; Messina, E; Ochoa, M; Shryock, JC; Walsh, E; Wu, Y; Xu, X; Zeng, D; Zhao, G1
Antzelevitch, C; Gibson, JK; Lynch, JJ; Pourrier, M; Sicouri, S1
Clauß, C; Eckardt, L; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Schmidt, M; Stypmann, J1
Carrier, L; Christ, T; Cuello, F; Eschenhagen, T; Flenner, F; Friedrich, FW; Geertz, B; Maier, LS; Reischmann, S; Schwedhelm, E; Söhren, KD; Stathopoulou, K; Ungeheuer, N; Wagner, S; Weinberger, F1
Ameen, AM; Tawfik, MK1
Barchukov, VV; Gudasheva, TA; Kryzhanovskii, SA; Likhosherstov, AM; Mokrov, GV; Tsorin, IB; Vititnova, MB1

Reviews

1 review(s) available for ranolazine and isoproterenol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

9 other study(ies) available for ranolazine and isoproterenol

ArticleYear
Effects of ranolazine on L-type calcium channel currents in guinea-pig single ventricular myocytes.
    British journal of pharmacology, 1996, Volume: 118, Issue:2

    Topics: Acetanilides; Acetylcholine; Adrenergic beta-Agonists; Animals; Calcium Channels; Guanylyl Imidodiphosphate; Guinea Pigs; Heart Ventricles; Histamine; In Vitro Techniques; Isoproterenol; Male; Piperazines; Ranolazine; Receptors, Adrenergic, beta

1996
Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system.
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:4

    Topics: Acetanilides; Adrenergic beta-Antagonists; Animals; Cardiovascular System; Enzyme Inhibitors; Guinea Pigs; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta

2001
Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities.
    Chemical & pharmaceutical bulletin, 2009, Volume: 57, Issue:11

    Topics: Acetanilides; Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Electrocardiography; Female; Glucose; Isoproterenol; Male; Mice; Mice, Inbred Strains; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine

2009
Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:6

    Topics: Acetanilides; Adrenergic Antagonists; Animals; Autonomic Agents; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Ganglionic Blockers; Guinea Pigs; Heart Rate; Hemodynamics; Hexamethonium; Hypertension; Hypotension; Isoproterenol; Kinetics; Phenylephrine; Piperazines; Ranolazine; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasoconstrictor Agents; Vasodilator Agents

2011
Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
    Heart rhythm, 2012, Volume: 9, Issue:3

    Topics: Acetanilides; Action Potentials; Adrenergic beta-Agonists; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Cardiac Electrophysiology; Cell Membrane; Dogs; Heart Rate; Humans; Isoproterenol; Membrane Potentials; Piperazines; Pulmonary Veins; Pyrrolidines; Ranolazine; Sodium Channels; Sotalol

2012
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.
    European journal of heart failure, 2012, Volume: 14, Issue:12

    Topics: Acetanilides; Acetylcholine; Animals; Atrial Fibrillation; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Female; Heart Conduction System; Heart Failure; Isoproterenol; Piperazines; Rabbits; Ranolazine; Signal Processing, Computer-Assisted

2012
Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.
    Cardiovascular research, 2016, Jan-01, Volume: 109, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Isoproterenol; Mice; Myocytes, Cardiac; Phosphorylation; Ranolazine; Sodium Channel Blockers

2016
Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis.
    Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:7

    Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Glycated Hemoglobin; Isoproterenol; Male; Myocardial Infarction; Oxidative Stress; Ranolazine; Rats; Rats, Wistar

2019
Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction.
    Bulletin of experimental biology and medicine, 2019, Volume: 167, Issue:4

    Topics: Animals; Electrophysiology; Hyperhomocysteinemia; Isoproterenol; Male; Myocardial Infarction; Ranolazine; Rats; Trimetazidine

2019